Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol in autologous HCT for multiple myeloma
NCT02420223Phase 2Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Jul 2015
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in multiple myeloma (MM), sponsored by Medical College of Wisconsin. Started Jul 2015; status: completed.
02
Drugs
propranolol
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02420223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02420223.